Are we wasting our time with the sentinel technique? Fifteen reasons to stop axilla dissection
Authors:
- J. EngelJEJ. Engel
- A. LebeauALA. Lebeau
- H. SauerHSH. Sauer
- D. HölzelDHD. Hölzel
- 1 June 2006
- journal article
- research article
- Published by Elsevier in The Breast
- Vol. 15 (3) , 451-454
Abstract
No abstract availableKeywords
This publication has 26 references indexed in Scilit:
- Clinical outcome of patients with lymph node‐negative breast carcinoma who have sentinel lymph node micrometastases detected by immunohistochemistryCancer, 2005
- Sentinel node biopsy in breast cancer: early results in 953 patients with negative sentinel node biopsy and no axillary dissectionEuropean Journal of Cancer, 2005
- Do metastases metastasize?The Journal of Pathology, 2004
- Axillary Treatment in Conservative Management of Operable Breast Cancer: Dissection or Radiotherapy? Results of a Randomized Study With 15 Years of Follow-UpJournal of Clinical Oncology, 2004
- Intra-mammary tumor location does not influence prognosis but influences the prevalence of axillary lymph-node metastasesJournal of Cancer Research and Clinical Oncology, 2003
- Stage at diagnosis is a key explanation of differences in breast cancer survival across EuropeInternational Journal of Cancer, 2003
- A Gene-Expression Signature as a Predictor of Survival in Breast CancerNew England Journal of Medicine, 2002
- Metastasis genes: A progression puzzleNature, 2002
- Predicting the survival of patients with breast carcinoma using tumor sizeCancer, 2002
- Does radical surgery to the axilla give a survival advantage in more severe breast cancer?European Journal of Cancer, 2002